首页> 外文期刊>Nature >Structural basis of nucleosome recognition and modification by MLL methyltransferases
【24h】

Structural basis of nucleosome recognition and modification by MLL methyltransferases

机译:MLL甲基转移酶识别和修饰核小体的结构基础

获取原文
获取原文并翻译 | 示例
       

摘要

Methyltransferases of the mixed-lineage leukaemia (MLL) family-which include MLL1, MLL2, MLL3, MLL4, SET1A and SET1B-implement methylation of histone H3 on lysine 4 (H3K4), and have critical and distinct roles in the regulation of transcription in haematopoiesis, adipogenesis and development(1-6). The C-terminal catalytic SET (Su(var.)3-9, enhancer of zeste and trithorax) domains of MLL proteins are associated with a common set of regulatory factors (WDR5, RBBP5, ASH2L and DPY30) to achieve specific activities(7-9). Current knowledge of the regulation of MLL activity is limited to the catalysis of histone H3 peptides, and how H3K4 methyl marks are deposited on nucleosomes is poorly understood. H3K4 methylation is stimulated by mono-ubiquitination of histone H2B on lysine 120 (H2BK120ub1), a prevalent histone H2B mark that disrupts chromatin compaction and favours open chromatin structures, but the underlying mechanism remains unknown(10-12). Here we report cryo-electron microscopy structures of human MLL1 and MLL3 catalytic modules associated with nucleosome core particles that contain H2BK120ub1 or unmodified H2BK120. These structures demonstrate that the MLL1 and MLL3 complexes both make extensive contacts with the histone-fold and DNA regions of the nucleosome; this allows ease of access to the histone H3 tail, which is essential for the efficient methylation of H3K4. The H2B-conjugated ubiquitin binds directly to RBBP5, orienting the association between MLL1 or MLL3 and the nucleosome. The MLL1 and MLL3 complexes display different structural organizations at the interface between the WDR5, RBBP5 and MLL1 (or the corresponding MLL3) subunits, which accounts for the opposite roles of WDR5 in regulating the activity of the two enzymes. These findings transform our understanding of the structural basis for the regulation of MLL activity at the nucleosome level, and highlight the pivotal role of nucleosome regulation in histone-tail modification.
机译:混合谱系白血病(MLL)家族的甲基转移酶-包括MLL1,MLL2,MLL3,MLL4,SET1A和SET1B-实现组蛋白H3在赖氨酸4(H3K4)上的甲基化,并且在转录调控中起关键作用和独特作用造血,脂肪形成和发育(1-6)。 MLL蛋白的C末端催化SET(Su(var。)3-9,zeste和trithorax的增强子)结构域与一组常见的调节因子(WDR5,RBBP5,ASH2L和DPY30)相关,以实现特定的活性(7 -9)。目前关于MLL活性调节的知识仅限于组蛋白H3肽的催化作用,而对H3K4甲基标记如何沉积在核小体上的了解很少。 H3K4甲基化是通过赖氨酸120(H2BK120ub1)上组蛋白H2B的单泛素化而刺激的,这是一种流行的组蛋白H2B标记,可破坏染色质的紧实度并促进开放的染色质结构,但其潜在机制仍然未知(10-12)。在这里,我们报告人类MLL1和MLL3催化模块与包含H2BK120ub1或未修饰的H2BK120的核小体核心颗粒相关的低温电子显微镜结构。这些结构表明,MLL1和MLL3复合物均与核小体的组蛋白折叠和DNA区域形成广泛接触。这使得易于接近组蛋白H3尾部,这对于H3K4的有效甲基化至关重要。 H2B结合的泛素直接结合RBBP5,定向MLL1或MLL3与核小体之间的结合。 MLL1和MLL3复合体在WDR5,RBBP5和MLL1(或相应的MLL3)亚基之间的界面处显示不同的结构组织,这解释了WDR5在调节两种酶活性中的相反作用。这些发现改变了我们对核小体水平上MLL活性调节的结构基础的理解,并突出了核小体调节在组蛋白尾修饰中的关键作用。

著录项

  • 来源
    《Nature》 |2019年第7774期|445-449|共5页
  • 作者单位

    Univ Chinese Acad Sci Chinese Acad Sci Shanghai Inst Biochem & Cell Biol CAS Ctr Excellence Mol Cell Sci State Key Lab Mol Shanghai Peoples R China;

    Shanghai Jiao Tong Univ Peoples Hosp 9 Sch Med Shanghai Inst Precis Med Shanghai Peoples R China;

    Chinese Acad Sci Shanghai Adv Res Inst Natl Facil Prot Sci Shanghai ZhangJiang Lab Shanghai Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号